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Low Macrophage
Content in Diabetic and
Aging Human Skeletal
Muscle
Dongmei Liu and Paul M. Gordon
TO THE EDITOR: The prevailing view-
point is that the accumulation of macro-
phages in adipose tissue plays a major role
in obesity-associated inflammation. How-
ever, an increase in skeletal muscle macro-
phage content and subsequent paracrine
effect has also been implicated in the patho-
genesis of muscle insulin resistance (1,2).
Yet, other studies have found minimal
amounts of macrophages in skeletal muscle
and no relation to adiposity levels (3). The
discrepancy in these findings may be due, in
part, to different methods used for determin-
ing macrophage contents. For example, in
obese human skeletal muscle, Varma et al.
used immunohistochemistry staining for
CD68 and found an increase in macrophage
count (1); whereas, Bruun et al. used real-
time polymerase chain reaction (RT-PCR) to
measure CD68 mRNA levels and reported
minimal macrophages that were unchanged
following weight loss (3). To clarify the role
of local macrophage in muscle insulin resist-
ance in obesity and diabetes, studies using
multiple methods to ascertain the quantity of
macrophages are needed. A recent short
communication by Tam et al. (4) represents
such a study, in which both immunohisto-
chemistry and gene expression were used to
assess muscle macrophage content in obese
diabetic and elderly individuals. Tam et al.
reported little evidence of macrophage accu-
mulation in muscle of obese diabetic
(2–3%) or elderly (4%) individuals, based
on immunohistochemistry staining for
CD68. This was much lower than
that observed by others who used similar
methods and reported approximately 25%
macrophages in the muscle of obese (1) and
elderly (5) individuals. Tam et al. suggested
that the reason for higher macrophage levels
found by others might be due to contamina-
tion by adipose tissue, given that they
observed greater CD68 staining in the inter-
muscular adipose tissue (IMAT) region of
obese diabetic muscle. Tam et al. chose to
exclude connective tissue and IMAT regions
in the muscle sections used for macrophage
counting, which we find concerning. Connec-
tive tissue and IMAT surrounding myofibers
likely influence myofiber function. As sug-
gested by Kewalramani et al., macrophages
infiltrating muscle tissue, whether bordering
the myofibers directly or surrounding mus-
cle-infiltrating adipocytes, might have a large
impact on muscle insulin activity (6). This
notion is supported by in vitro studies, where
conditioned medium collected from palmitic
acid-treated macrophages resulted in a signif-
icant decrease in insulin-mediated glucose
uptake in both cultured human muscle
myotubes (1) and L6 myotubes (7).
Animal studies indicate that resident macro-
phages are extensively present in the con-
nective tissue surrounding myofibers (8).
Moreover, enlarged IMAT likely attracts
monocyte-derived macrophages (9). There-
fore, we feel that connective tissue and
IMAT are important regions to examine for
abnormalities in muscle macrophages.
Excluding these compartments of muscle tis-
sue could lead one to overlook the potential
contribution of local macrophages to muscle
metabolic dysfunction in obesity and aging.
Additionally, we are curious about the
changes in macrophages following the exer-
cise intervention in the diabetic patients.
Although no significant change was reported,
there appears to be an increase in macrophage
content in at least half of the subjects based
on the median and interquartile ranges at
baseline 2.7 (2.0–3.2%) and postintervention
4.0 (3.2–6.8%).O
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Better Measurement
Needed to Move
Food-Environment
Research Forward
Sean C. Lucan and Earle C. Chambers
TO THE EDITOR: Dubowitz et al. pro-
vide the latest data linking select aspects of
local food environments to select obesity-
related health measures (1). The authors’
lengthy limitations section highlights some
of the measurement challenges to conduct-
ing this type of research. If future research
is to identify the most promising strategies
to improve food environments, support
healthy eating, and prevent obesity, then the
field needs to move beyond some common
measurement limitations of early studies.
First, the use of unvalidated business-list data
is precarious. Although such data were
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convenient and efficient for establishing foun-
dational associations in early studies, they are
less than ideal for the field moving forward.
For example, based on detailed ground obser-
vations of all food sources from >150 Bronx
streets, research in our group has shown the
business list used by Dubowitz et al to have a
positive predictive value below 50% overall,
and a sensitivity for grocery stores of only
about 25% (manuscript under preparation).
Other researchers have reported similar find-
ings (and the business list having a sensitivity
of <10% for fast food) (2). More-accurate
food-environment data, verified on-the-
ground, are needed.
Beyond issues of accuracy, the concern with
reliance on business lists is two-fold: [1] it
inappropriately groups all food sources of a
certain type (e.g., as if every supermarket
were the same as every other supermarket in
terms of selection and quality of products,
when empirically this is not the case (3)),
[2] it generally restricts focus to a limited
range of food outlets (e.g., ‘‘fast-food restau-
rants,’’ ‘‘grocery stores and supermarkets’’
(1)). Studies using business-lists necessarily
neglect impermanent sources of food that
may be relevant, like street vendors (4,5) and
farmers’ markets (6,7). They also routinely
neglect–more due to investigator decision as
opposed to data deficiency a range of other
potentially relevant food sources like phar-
macies, gas stations, hotels, salons, general
merchandisers, clothing outlets, book stores,
and other retail selling food and drink (8).
More-complete availability measures, that
include generally neglected food sources, are
needed.
A separate issue concerns definitions of
food-source proximity. While studies like
that of Dubowtiz et al commonly use radial
‘‘buffers’’ (1), such buffers ignore how peo-
ple travel in their environments and their
barriers to transit. For example, one-way
streets and divided highways have different
implications for motorists than for pedes-
trians, and research that fails to consider
how people actually access food may miss
relevant associations (9). An alternative
approach to radial buffers, favored by geog-
raphers, is to measure accessibility along
existing street networks for walking or driv-
ing (10). More-precise accessibility meas-
ures, that consider how people travel to get
food, are needed.
Dubowitz et al. conclude that their findings
support restricting the development of fast-
food outlets and attracting grocery stores
(1). Given measurement limitations, includ-
ing those above, we do not find strong sup-
port for this conclusion. Perhaps greater
benefit would come from promoting famers’
markets and produce carts … or from
restricting the sale of unhealthy foods at sal-
ons and pharmacies (but maybe only for
those along walking routes and not for those
accessed by motor vehicles). To investigate
such possibilities and understand different
options for intervention, it is time for the
field to move beyond the limitations of early
research, making use of more accurate, com-
plete, and precise measures.O
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Response to ‘‘Lack of
Evidence to Support a
Beneficial Role for
Glutathione Depletion
on Body Weight or
Glucose Intolerance’’
Hannes M. Findeisen
and Dennis Bruemmer
TO THE EDITOR: We appreciate the
concerns shared by Dr. Sekhar regarding our
recently published manuscript. With respect to
the title of the letter to the Editor by Dr.
Sekhar ‘‘Lack of evidence to support a
beneficial role for glutathione depletion on
body weight or glucose intolerance’’ it appears
pertinent to first summarize the available liter-
ature that has addressed the role of glutathione
depletion in obesity and metabolism. Abun-
dant evidence has now revealed that mice ge-
netically deficient for glutathione or glutathi-
one peroxidase are resistant to weight gain and
diet-induced obesity, are protected from glu-
cose intolerance and insulin resistance, do not
develop hepatic steatosis, and exhibit a higher
metabolic rate (1–4). Therefore, there is
indeed unequivocal evidence that glutathione
depletion elicits a phenotype in mice that is
beneficial for body weight regulation and glu-
cose homeostasis. Moreover, our data using a
well-established pharmacological model of
glutathione depletion are entirely consistent
with this evidence obtained from genetic mod-
els. Due to the nature of our article being a
short communication and considering the
extensive literature describing buthionine sul-
foximine (BSO)-induced glutathione depletion
in rodents (5,6), we did not show glutathione
reduction in our initial manuscript. However,
we found a reduction of almost 70% in total
glutathione levels in epididymal adipose tissue
of BSO treated mice (P < 0.05). The extent of
glutathione reduction in response to BSO in
our studies is similar to that previously seen in
pharmacologic or genetic models of glutathi-
one depletion (2,5,7).
With respect to the second comment on
the measurements of food intake, these
experiments were performed following the
guidelines set forth by the National Institutes
of Health (NIH)-funded Mouse Metabolic
Phenotyping Centers (8). Specifically, we
employed a calorimetry system that provided
investigator-independent automated feeding
systems. Food intake was measured
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cumulatively during a 72 h time period and
expressed as gram food consumption per day.
Our observation that BSO-treatment did not
affect food consumption is, again, in line with
various previous publications demonstrating
normal food intake in BSO-treated mice (5,9)
as well as with the above-described genetic
models of glutathione depletion (2). Nonethe-
less, we agree with Dr. Sekhar that further
comprehensive studies to define this intrigu-
ing phenotype are warranted, including partic-
ularly pair-feeding experiments.
Finally, Dr. Sekhar expresses concerns about
possible toxic effects of BSO. We have elected
to treat mice with a dose of 30 mM BSO
because this dose has been previously demon-
strated to effectively decrease glutathione in
mice (7). Moreover, extensive characterization
of various organ functions in mice treated with
this dose, including liver function tests and
cytochrome P-450 concentrations, revealed no
toxic effects after prolonged treatment (7). In
our study, high fat diet fed mice exhibited a
significant increase in liver weight during the
course of the study, an effect likely secondary
to steatosis. In contrast, the development of
this phenotype was prevented in BSO-treated
mice (data not shown). This observation is
consistent with data obtained in mice that are
genetically deficient for glutathione and has
been attributed to a specific beneficial effect
of glutathione depletion on the expression of
lipogenic genes (2,3,6). Consequently, it is not
surprising that the authors of the study referred
to by Dr. Sekhar (9) also noted an effect of
BSO on liver weight. However, in this study
Watanabe et al. (9) did not observe any avoid-
ance of food/water intake, and the authors did
not interpret 30 mM of BSO as hepatotoxic,
considering that BSO did not increase alanine
transaminase (ALT), alkaline phosphatase
(ALP), or the expression levels of drug-metab-
olizing pathways (albeit a modest isolated
increase in aspartate transaminase (AST) lev-
els). Collectively, these studies do not support
the assumption that the dose of 30 mM BSO
used in our studies elicited toxic activities that
contribute to the beneficial obesity and metab-
olism phenotype.
In summary, our manuscript supports a more
complex role of glutathione in the regulation
of energy balance and metabolism than previ-
ously anticipated. We acknowledge that our
manuscript, collectively with the discussed
literature, challenges the conventional hy-
pothesis that depletion of glutathione may be
detrimental for obesity and metabolism.
Determining the molecular mechanisms
underlying these phenotypes and potential
pathological consequences constitute impor-
tant avenues for future research.O
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Response to Low
Macrophage Content in
Diabetic and Aging
Human Skeletal Muscle
Charmaine S. Tam1,2,
Jeffrey D. Covington1
and Eric Ravussin1
TO THE EDITOR: The pro-inflammatory
role of macrophage accumulation in white
adipose tissue in obesity is well established
and may be one of the causes of insulin re-
sistance. Whether macrophage accumulation
in skeletal muscle further contributes to the
inflammatory state and insulin resistance is
less clear. We, therefore, measured inflam-
mation gene expression and CD68þ macro-
phages in skeletal muscle from obese sub-
jects with type 2 diabetes mellitus before
and after a 9-month exercise intervention
(1). In contrast to previous studies in simi-
larly obese subjects (2,3), we found rela-
tively few macrophages (2-3%) and low
inflammation gene expression (CD68,
CCL2, CD40, CD206, CD11c, Arginase 1)
in obese skeletal muscle, which was
unchanged after exercise training (1).
We examined skeletal muscle sections, deliber-
ately excluding areas of connective tissue and
adjacent adipose tissue, and concluded that
greater macrophage accumulation in other stud-
ies may potentially be due to contamination
with adipose tissue. In response to our report
(1), Liu and Gordon pointed out that connective
tissue and inter-muscular adipose tissue
(IMAT) may be important regions to examine
macrophages in skeletal muscle (4). Indeed,
recent studies in subcutaneous and omental adi-
pose tissue in obese humans have demonstrated
that connective tissue regions (fibrotic areas
within adipose tissue) contain macrophages
(M1 and M2 phenotype) and mast cells, with
few T lymphocytes (5). Spencer et al. found
higher macrophage accumulation in fibrotic
areas in obese compared to lean subjects (6).
Together, these studies indicate potential
cross-talks between inflammatory cells in
fibrotic areas and the adipocyte, which may
further exacerbate obesity-associated low
grade inflammation and potential insulin re-
sistance (5,6). As pointed out (4), it is possi-
ble that immune cells may also be present in
connective tissue areas in skeletal muscle, as
shown in rodents (7) but yet not in humans.
Interestingly, when we re-examined our skel-
etal muscle sections, we saw few to no areas
of connective tissue (data not shown).
Liu and Gordon also suggest that macro-
phages may be present in IMAT which is
located between muscle bundles and clearly
separated from subcutaneous adipose tissue
(8). Magnetic resonance imaging studies
demonstrate that such fat depots are approxi-
mately twofold higher in subjects with obe-
sity and type 2 diabetes (8). Furthermore, in
vitro co-culturing of human myotubes and
adipocytes results in impaired insulin action
depending on the metabolic state of the sys-
tem (9). Unfortunately, IMAT depots are
www.obesityjournal.org Obesity | VOLUME 21 | NUMBER 1 | JANUARY 2013 4
Obesity Letters to the Editor
difficult if not impossible to obtain from
muscle biopsies. In addition, in response to
the authors’ comments, we re-examined the
raw data and noted that 5 out of the 7 sub-
jects had relatively small increases in macro-
phage accumulation after exercise training.
In summary, there is a need for further
investigations examining inflammation in
skeletal muscle in the context of obesity and
type 2 diabetes and its potential role in
mediating insulin resistance. In vitro studies
using palmitate treated macrophages have
demonstrated impaired insulin-mediated
glucose uptake in cultured human (2) and
L6 myotubes (10). Exploring immune cells
in areas of connective tissue and adjacent
adipose tissue clusters in skeletal muscle
from obese subjects may provide further
insights into muscle inflammation.O
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Food Policy Research:
We Need Better
Measurement, Better
Study Designs, and
Reasonable and
Measured Actions
Based on the Available
Evidence
Tamara Dubowitz1,
Madhumita (Bonnie) Ghosh-Dastidar2,
Rebecca Collins3 and Jose Escarce4
TO THE EDITOR: Lucan and Chambers,
in their Letter to the Editor, call for better
measurement in order to move food-environ-
ment research forward. We wholeheartedly
agree. In fact, this issue is not new to the
obesity policy agenda (1). However, attain-
ing validated and detailed food environment
data in a large-scale (e.g., national) setting
is prohibitively costly. Our study included
68,132 women living in 18,186 census tracts
across the United States (2). We excluded
women who lived in census tracts with a
population count of less than 500 and
women living outside metropolitan statistical
areas because we believed measures of the
food environment would not be comparable
in urban and rural areas. As we pointed out
in our article, most studies to date have ana-
lyzed a single type of food outlet (e.g., gro-
cery stores or fast-food outlets) at one time.
We examined multiple dimensions of the
food environment in a national dataset—and
believe that these data and analyses bring
the state of the literature forward. We con-
cur that detailed ground observations, such
as the ones Lucan and Chambers reference,
are ideal. However, these can only be exe-
cuted in confined geographic settings. Such
data would be extremely difficult, if not
impossible, to attain on a national scale.
We also agree with Lucan and Chambers’
concerns with (1) assumptions that establish-
ments categorized as full-service supermar-
kets are all comparable; (2) potentially rele-
vant food sources such as farmers’ markets
and mobile produce stands may not be cap-
tured through commercial database listings;
and (3) using radial buffers and proximity to
a store to capture access without capturing
factors such as transportation mode, travel
time, and social norms around food purchas-
ing. Such detailed evidence can complement
and validate studies based on large national
data to ensure that policies are based on a
solid scientific foundation.
Importantly, we are working on that. Mem-
bers of our team are involved with the largest
study to date in the United States that is capi-
talizing on a natural experiment of the elimi-
nation of a food desert (1R01CA149105,
Does a New Supermarket Improve Dietary
Behaviors of Low-income African Ameri-
cans?). Examination of a natural experiment
of this type (i.e., elimination of a food desert)
is allowing our team to overcome many of
these limitations, from reliance on unvali-
dated commercial databases (we are conduct-
ing food audits to collect price, quality, and
availability of food data from all food pur-
chasing venues in residential neighborhoods
included in our study as well as the most fre-
quently report venues our enrolled population
reports shopping), to a longitudinal quasi-ex-
perimental study design with a control or
comparison neighborhood, and extensive data
on residents’ dietary intake, travel mode, time
spent in shopping, and experience of
food purchasing. We have just completed
our baseline data collection and hope that
findings from this study when completed will
be replicable to other low-income African
American neighborhoods across the United
States. However, we are indeed confined to
one large natural experiment and unlike our
published study, will not be analyzing data
based on tens of thousands of individuals and
census tracts.
We agree that the field faces measurement
limitations. Large observational studies,
such as the one our paper reported, have
imperfect measures. However, given the
considerable impact of nutrition on obesity
and other health problems, we believe that
reasonable and measured actions based on
the available evidence need to be consid-
ered. Policy makers cannot afford to rely
solely on data from detailed studies of a few
neighborhoods (one could argue a require-
ment for grounding approaches) and need to
know whether results hold at a national
level. Our study does that, and the methods
we used are necessary to such a study.
Although we agree that the field also needs
studies of small areas with rich and detailed
measures to complement the national data
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and help us determine their validity, we still
conclude that our findings support restricting
the development of fast-food outlets and
attracting grocery stores, and are committed
to additional research that overcomes the
limitations of large studies such as the one
we published.O
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Adolphe Quetelet and
the BMI: Fact, Fiction,
and Childhood Growth
Richard F. Burton
TO THE EDITOR: It is often stated, with
or without supporting references, that the
BMI was proposed by Adolphe Quetelet
(e.g., see Refs. 1,2). However, I find no evi-
dence for this in his own writings, of which
I cite only three here (3–5). What he did
assert was that body mass in adults tends to
vary with the square of height (3–5).
Less often noted is that he also wrote that
mass2 increases with height5 in adolescents
(3–5), implying that a more appropriate ver-
sion of the BMI for them is not mass/
height2, but mass/height2.5. This accords
approximately with values of p in the Benn
Index (i.e., mass/heightp) tabulated in a no-
table paper by Cole for successive one-year
age groupings (6). (That height and mass
were standardized for age is unimportant
here.) Estimates of p were generally 2.2-3.3
in children between four and about 15 years
of age. The highest values tended to occur
around the time of puberty. None signifi-
cantly exceeded 3.0, which is the value
Quetelet recognized as appropriate to iso-
metric growth (3–5).
The variation in p largely relates to variation in
the correlation coefficient, rMH, for the loga-
rithms of mass-for-age and of height-for-age.
Cole’s Table 2 reveals a marked correlation
between the values of p and rMH in both boys
and girls from the age of six (n¼ 40; r ¼ 0.89;
P < 1010). This recalls a similar correlation
between estimates of p and the respective cor-
relation coefficients for mass and height in
adults (7). In the children, again from the age
of six, the 40 values of rMH correlated with the
standard deviations of log(height-for-age) (r ¼
0.55; P < 0.0002). Thus, in those age groups
in which the adolescent growth spurt makes
height most variable, rMH tends to be highest
and p tends to be closest to 3.
The correlations between p and rMH in
adults and children are inherent in the statis-
tical techniques used in estimating p (7).
With adequate samples, the estimates that
they produce will always be less than the
true (functional) values. It means that Quete-
let’s assertion and continuing common
belief, that adult body mass tends to vary
with height2, is actually wrong (though this
does not invalidate the BMI as a predictor
of %adiposity in adults). The apparent al-
lometry in adults is largely or entirely a sta-
tistical artifact. The childhood peak in p is
also largely or entirely a statistical phenom-
enon, explainable in terms of growth, but
not of changing bodily proportions such as
might relate to adiposity. The statistical
reasoning is uncommon in anthropometry
and can seem counterintuitive, but it is read-
ily tested by Monte Carlo modeling (7).O
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Single Slice vs.
Volumetric MR
Assessment of Visceral
Adipose Tissue:
Reliability and Validity
Among the Overweight
and Obese
Siamak Sabour, MD, PhD
TO THE EDITOR: I was interested to read
the paper by Maislin et al. published in the
May 2012 issue of Obesity. The authors
assessed reliability and validity of single
slice vs. volumetric MR of visceral adipose
tissue (VAT) among the overweight and
obese and reported that the correlation with
VAT volume was significantly larger for
L2-L3 VAT area (r ¼ 0.96) compared to
L4-L5 VAT area (r ¼ 0.83) (1). These
correlation computations do not reflect reli-
ability and validity analysis and is a com-
mon mistake in reliability analysis (2-4). I
found the manuscript title of Maislin et al.
incorrect and misleading. Moreover, they
reported a strong positive correlation between
variables in both areas; clinically 0.13 differ-
ences in r means nothing, although it was
statistically significant. As a rule of thumb in
clinical epidemiology, clinical importance
should be considered a priority instead of
statistically significant. The P value can eas-
ily be changed from significant to non-signif-
icant due to small sample size, the amount of
mean difference, and more important factor
which is standard deviation of the variable in
the study population (2-4). As the authors
point out in their conclusion, linear regres-
sion analyses demonstrated that L2-L3 area
alone was sufficient for predicting total VAT
volume. The common practice is to employ
two different sets of cohort data for
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developing and validation of a prediction
model, and it is unclear why the authors did
not consider employing such practice. The
authors also did not utilize Area Under the
Curve (AUC) analysis, which would have
added diagnostic value to the study (2-4).
Reliability and validity are two completely
different methodological issues in researches.
Sensitivity, specificity, positive predictive
value (PPV), negative predictive value
(NPV), likelihood ratio positive (LRþ: true
positive/false positive) and likelihood ratio
negative (LR: false negative/true negative)
as well as odds ratio (true results/false
results—preferably more than 50) are among
the tests to evaluate the validity (accuracy) of
a single test compared to a gold standard (2-
4). Reliability (repeatability or reproducibil-
ity) is being assessed by different statistical
tests such as Pearson r, least square, and
paired t test which all of them are among
common mistakes in reliability analysis (5).
Briefly, for quantitative variable intra class
correlation (ICC) coefficient and for qualita-
tive variables weighted kappa should be used
with caution because kappa has its own limi-
tation too. Regarding reliability or agree-
ment, it is good to know that for computing
kappa value, just concordant cells are being
considered, whereas discordant cells should
also be taking into account in order to reach
a correct estimation of agreement (weighted
kappa) (2-4). It is crucial to know that there
is no value of kappa that can be regarded uni-
versally as indication of good agreement.
Statistics cannot provide a simple substitute
for clinical judgment. Two important weak-
nesses of k value to assess agreement of a
qualitative variable are as follow: It depends
on the prevalence in each category and also
depends on the number of categories. So it is
obvious that the less our categories, the
higher will be our kappa value which can
easily lead to misinterpretation (2-4).
Area under the curve (AUC) is usually
reported for diagnostic rather prognostic
values of a model. The Receiver Operative
Curve (ROC) for models may be compara-
ble with LRþ for a test because both of
them actually use sensitivity and 1-speci-
ficity; however, in LRþ they are divided
and in the ROC we should plot sensitivity
to 1-specificity. As a take home message,
for reliability and validity analysis, appro-
priate tests should be applied.O
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